WallStreetZenWallStreetZen

NASDAQ: BFRI
Biofrontera Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BFRI past revenue growth

How has BFRI's revenue growth performed historically?
Company
18.82%
Industry
10.14%
Market
17.55%
BFRI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BFRI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BFRI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BFRI earnings and revenue history

Current Revenue
$34.1M
Current Earnings
-$20.1M
Current Profit Margin
-59.1%

BFRI Return on Equity

Current Company
-270.6%
Current Industry
15.4%
Current Market
188%
BFRI's Return on Equity (-270.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BFRI announces earnings.

BFRI Return on Assets

Current Company
-57.1%
Current Industry
3.4%
BFRI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BFRI Return on Capital Employed

Current Company
-199.6%
Current Industry
5.1%
BFRI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BFRI vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BFRI$34.07M-$18.59M-$20.13M+6.81%N/A
UPC$32.31M-$3.18M-$6.16M-0.70%N/A
COSM$49.59M-$12.79M-$42.91M+4.62%N/A
CLVR$17.42M-$14.94M-$17.90M+22.11%N/A
SHPH$0.00-$4.09M-$6.59MN/AN/A
View Top Pharmaceutical Stocks

BFRI earnings dates

Next earnings date
Jun 12, 2024

Biofrontera Earnings & Revenue FAQ

What were BFRI's earnings last quarter?

On Invalid Date, Biofrontera (NASDAQ: BFRI) reported Q4 2023 earnings per share (EPS) of $4.55, up 262.5% year over year. Total Biofrontera earnings for the quarter were $3.53 million. In the same quarter last year, Biofrontera's earnings per share (EPS) was -$2.80.

If you're new to stock investing, here's how to buy Biofrontera stock.

What was BFRI's earnings growth in the past year?

As of Q2 2024, Biofrontera's earnings has grown year over year. Biofrontera's earnings in the past year totalled -$20.13 million.

What is BFRI's earnings date?

Biofrontera's earnings date is Invalid Date. Add BFRI to your watchlist to be reminded of BFRI's next earnings announcement.

What was BFRI's revenue last quarter?

On Invalid Date, Biofrontera (NASDAQ: BFRI) reported Q4 2023 revenue of $10.60 million up 4.46% year over year. In the same quarter last year, Biofrontera's revenue was $10.14 million.

What was BFRI's revenue growth in the past year?

As of Q2 2024, Biofrontera's revenue has grown 18.82% year over year. This is 8.68 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.14%. Biofrontera's revenue in the past year totalled $34.07 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.